MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/77.5/0.1/20.06.25 Stock MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/77.5/0.1/20.06.25
Add to a list
To use this feature you must be a member
Log inSign up

MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/77.5/0.1/20.06.25 Stock

Warrant

DE000ME3JA40

Market Closed - Börse Stuttgart 12:44:47 2024-06-28 pm EDT
0.84 EUR +1.20% Intraday chart for MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/77.5/0.1/20.06.25
1 month+9.09%
3 months+133.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart ASTRAZENECA PLC
Chart MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/77.5/0.1/20.06.25

Latest news about ASTRAZENECA PLC

Presage Biosciences Announces New Pharma Partnership to Evaluate Novel Immuno-Oncology Drug Combinations with CIVO® Technology PR
New analysis of Phase II data at AACR assesses ImaginAb's investigational CD8 ImmunoPET technology's ability to predict response in immunotherapy PR
Invitae Announces Partnership for Real-World Data Sharing to Inform Rare Cancer Research PR
Baili Announces Clinical Trial Collaboration to Evaluate SI-B001, an EGFR x HER3 bispecific Antibody, in Combination with Tagrisso® in Patients with Non-Small Cell Lung Cancer PR
More news

Quotes 5-day view

Date Price Change
24-06-28 0.84 +1.20%
24-06-27 0.83 -5.68%
24-06-26 0.88 -1.12%
24-06-25 0.89 +1.14%
24-06-24 0.88 +2.33%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 12:44 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ASTRAZENECA PLC
Issuer Morgan Stanley
WKN ME3JA4
ISINDE000ME3JA40
Date issued 2023-11-13
Strike 77.5 $
Maturity 2025-06-20 (356 Days)
Parity 10 : 1
Emission price 0.43 €
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.99 €
Lowest since issue 0.158 €
Delta0.59x
Omega 5.214
Premium10.74x
Gearing8.82x
Moneyness 1.006
Difference Strike -0.49 $
Difference Strike %-0.63%
Spread 0.01 €
Spread %1.20%
Theoretical value 0.8250
Implied Volatility 25.26 %
Total Loss Probability 49.31 %
Intrinsic value 0.0434
Present value 0.7816
Break even 86.34 €
Theta-0.01x
Vega0.03x
Rho0.03x

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
More about the company

Ratings for AstraZeneca PLC

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: AstraZeneca PLC

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
156.2 USD
Average target price
174.4 USD
Spread / Average Target
+11.69%
Consensus
  1. Stock Market
  2. Warrants
  3. Warrant